366017-09-6 Mubritinib
| 상품명칭 |
Mubritinib |
| 영문 이름 |
Mubritinib;1-(4-(4-((2-((1E)-2-(4-(Trifluoromethyl)phenyl)ethenyl)-4-oxazolyl)methoxy)phenyl)butyl)-1H-1,2,3-triazole; 1-(4-{4-[(2-{(E)-2-[4-(trifluoromethyl)phenyl]ethenyl}-1,3-oxazol-4-yl)methoxy]phenyl}butyl)-1H-1,2,3-triazole |
| 분자식 |
C25H23F3N4O2 |
| 분자량 |
468.4709 |
| InChI |
InChI=1/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+ |
| cas번호 |
366017-09-6 |
| 분자 구조 |
|
| 밀도 |
1.25g/cm3 |
| 비등점 |
620.9°C at 760 mmHg |
| 굴절 지수 |
1.577 |
| 인화점 |
329.3°C |
| 증기압 |
2.43E-15mmHg at 25°C |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
KR
CN
CZ
DE
EN
ES
FR
GR
HU
ID
IL
IN
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
